FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080553 [Registered on: 14/02/2025] Trial Registered Prospectively
Last Modified On: 13/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [Churna]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To study the effect of shatpushpadi churna and vaishwaner churna in Rhumatoid Arthritis disease 
Scientific Title of Study   A Randomized controlled clinical trial to evaluate the efficacy of shatpushpadi churna with vaishwaner churna in alleviating the symptoms of Amavata w.s.r. to Rheumatoid Arthritis  
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sanghamitra Shivajirao Khope 
Designation  PG scholar 
Affiliation  Vidarbha Ayurved Mahavidyalaya,Amravati 
Address  OPD No.09,Kayachikitsa Department,Vidarbha Ayurved Mahavidyalaya,Dhanvantari Nagar,Amravati,Maharashtra. Amravati MAHARASHTRA 444605 India

Amravati
MAHARASHTRA
444605
India 
Phone  09370514909  
Fax    
Email  sanghamitrakhope6789@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Vd Vaishali H Wankhade 
Designation  Guide and HOD Department oh Kayachikitsa 
Affiliation  Vidarbha Ayurved Mahavidyalaya 
Address  OPD No.09,Kayachikitsa Department,Vidarbha Ayurved Mahavidyalaya,Dhanvantari Nagar,Amravati,Maharashtra. Amravati MAHARASHTRA 444605 India

Amravati
MAHARASHTRA
444605
India 
Phone  9420125432  
Fax    
Email  vaishalivhww@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sanghamitra Shivajirao Khope 
Designation  PG scholar 
Affiliation  Vidarbha Ayurved Mahavidyalaya 
Address  OPD No.09,Kayachikitsa Department,Vidarbha Ayurved Mahavidyalaya,Dhanvantari Nagar,Amravati,Maharashtra. Amravati MAHARASHTRA 444605 India

Amravati
MAHARASHTRA
444605
India 
Phone  09370514909  
Fax    
Email  sanghamitrakhope6789@gmail.com  
 
Source of Monetary or Material Support  
Vidarbha Ayurved Mahavidyalaya and Hospital, Amravati,444605, India. 
 
Primary Sponsor  
Name  Vidarbha Ayurved Mahavidyalaya 
Address  Vidarbha Ayurved Mahavidyalaya,Dhanvantari Nagar,Amravati 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
nil  nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sanghamitra Shivajirao Khope  Vidarbha Ayurved Mahavidyalaya, Amravati.  OPD No.09,Kayachikitsa Department,Vidarbha Ayurved Mahavidyalaya,Dhanvantari Nagar,Amravati,Maharashtra. Amravati MAHARASHTRA 444606 India
Amravati
MAHARASHTRA 
9370514909

sanghamitrakhope6789@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
S.H.V.P.M. Vidarbha Ayurved Mahavidyalaya Amravati   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M059||Rheumatoid arthritis with rheumatoid factor, unspecified. Ayurveda Condition: AMAVATAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Vaishwaner Churna, Reference: Bhaishjya Ratnavali, Route: Oral, Dosage Form: Churna/ Powder, Dose: 6(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 43 Days, anupAna/sahapAna: Yes(details: Koshna jal), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Shatpushpadi churna, Reference: Bhaishjya Ratnavali, Route: Oral, Dosage Form: Churna/ Powder, Dose: 6(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 43 Days, anupAna/sahapAna: Yes(details: Koshna jal), Additional Information: -
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Subject having age group 20 to 60 years irrespective of their sex, caste,marital status and economic class.
Patient will be selected as per classical symptoms of amavata.
Patient having RA FACTOR positive 
 
ExclusionCriteria 
Details  Patients below 20 years and above 60 years of age.
Lactating and pregnant women.
Patient with evidence of malignancy.
Patients on chronic steroid usage.
Those suffering from any systemic illness like heart failure,dibetic mellitus,hepatic disorders. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Complete remission from amavata(Arthritis)
Marked improvement in amavata(Arthritis)
Mild improvement in amavata (Arthritis).
Mild improvement in amavata(Arthritis). 
0th day
7th day
14th day
21th day
28th day
43th day
58th day
73th day  
 
Secondary Outcome  
Outcome  TimePoints 
Sandhi shoola[joint pain]
Sandhi shotha[joint swelling]
Sandhi stabdhata[Morning stiffness]
Aruchi[Anorexia]
Jwara[Fever]
Vidvibandha[Constipation] 
43th day
58th day
73th day 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   25/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
A Randomised controlled clinical trial  to evaluate the effecacy of  Shatpushpadi Churna and Vaishwaner Churna in Amavata with special reference to Rhumatoid Arthritis.

Tral will be conducted in our institute . Total 60 patients diagnosed with classical signs and symptoms of Amavata   will be selected and then will be divided in two groups.

Shatpushpadi Churna will be given to one group and Vaishwaner Churna  will be given to another one.

The study will be conducted for 60 days. Results will be compared in two groups. 
Data analysis will be done by using appropriate statistical test. Primary outcomes will be to study the effectiveness of Shatpushpadi Churna and Vaishwaner Churna in Amavata and complete, moderate and mild remission of Amavata in patients.
 
Close